This symposium is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation. The theme is “Helminths: New insights from immunity to global health”.
Session
Helminth control: Drug development
Date: Wednesday, 11 December 2019
Time: 17:00-19:00
Chairs: Makedonka Mitreva, Washington University School of Medicine, USA, and Peter Nejsum, Aarhus University, Denmark
| Novel strategies for drug development Philip T. LoVerde, University of Texas Health Science Center, USA |
| Short Talk: Controlling schistosomiasis: appraisal of the scope of action of Praziquantel, the only available WHO-approved drug Justin Nono Komguep, Medical Research Centre, Institute of Medical Research and Medicinal Plant Studies, IMPM, Cameroon |
| Short Talk: Host genetics primarily regulates liver fibrosis in children from schistosomiasis endemic areas in rural Cameroon Severin Donald Kamdem, University of Cape Town, South Africa |
| Improved treatments for soil-transmitted helminthiases Jennifer Keiser, Swiss Tropical and Public Health Institute, Switzerland |
| Short Talk: Development of alternative treatments against filarial diseases Sabine Specht, Head of Filarial Clinical Programme, DNDi, Switzerland |
| Short Talk: DeWorm3: Results from the baseline survey for soil-transmitted helminths Sitara Swarna Rao Ajjampur, Christian Medical College, India |
More information:
